Homonataloin in Aloe species.

Homonataloin in Aloe species. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Homonataloin in Aloe species. Abstract Text:

J Beaumont,R Reynolds,J G Vaughan,

Homonataloin levels in exudates from cut leaves of a number of ALOE species from the Kew collection have been measured by absorption at 295 nm following separation by reversed phase HPLC. The level was found to be highest in the leaves just below the apex of the plant and to decrease in the older leaves. A range of concentrations was observed in the very variable species A. NYERIENSIS Christian but no taxonomically significant discontinuities were apparent. Other ALOE species containing homonataloin have been examined and levels from 14 per cent to 47 per cent of the exudate dry weight according to species were found.

Homonataloin in Aloe species. Publishing Authors By Initials

J Beaumont,R Reynolds,JG Vaughan,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Homonataloin in Aloe species. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Planta medica

VOLUME: 50

Page Numbers: 505-8

Journal Abbreviation: Planta Med.

ISSN: 0032-0943

DAY: 6

MONTH: Dec

YEAR: 1984

Homonataloin in Aloe species. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 66751

Homonataloin in Aloe species. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Homonataloin in Aloe species. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Homonataloin in Aloe species.

AFFILIATION: Department of Biological Sciences, Queen Elizabeth College, Campden Hill Road, London, W. 8., U.K.

Country: Germany

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Planta Med

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Homonataloin in Aloe species Related Publications

• ATP-Binding cassette cholesterol transporters and cardiovascular disease.
• Actions of the endocannabinoid transport inhibitor AM404 in neuropathic and inflammatory pain models.
• Allergic problems in the upper respiratory tract, including the ear.
• Alternative splicing yields novel BMAL2 variants: tissue distribution and functional characterization.
• Anemias of infancy and childhood.
• Antiproliferative agents alter vascular plasminogen activator inhibitor-1 expression: a potential prothrombotic mechanism of drug-eluting stents.
• Bone marrow plasminogen activator inhibitor-1 influences the development of obesity.
• Central adiposity and risk of Barrett's esophagus.
• Dielectric behavior of linear polyelectrolytes.
• Dielectric behavior of polyelectrolytes II. The cylinder.
• Dielectric behavior of polyelectrolytes III. The role of counterion interactions.
• Disclosure of date/acquaintance rape: who reports and when.
• Epidemiology and pathogenesis of esophageal cancer.
• Extending Fitts' Law to manual obstacle avoidance.
• Homonataloin in Aloe species.
• Long-Term Experience With 5-alpha-Reductase Inhibitors.
• Long-Term Experience with 5-alpha-Reductase Inhibitors.
• Macrophage TNF-alpha contributes to insulin resistance and hepatic steatosis in diet-induced obesity.
• Markedly impaired fibrinolytic balance contributes to cardiovascular risk in adults with growth hormone deficiency.
• Mutagen sensitivity and neoplastic progression in patients with Barrett's esophagus: a prospective analysis.
• NHS set for pound13m net surplus despite rising levels of debt.
• Plasminogen activator inhibitor-1 has a circadian rhythm in blind individuals.
• Population dynamics of Plasmodium sporogony.
• Reactive site-dependent phenotypic alterations in plasminogen activator inhibitor-1 transgenic mice.
• Regulation of the dopamine transporter by phosphorylation.
• Selective dorsal rhizotomy: long-term experience from Cape Town.
• Sexually mediated shedding of Myxobolus fallax spores during spermiation of Litoria fallax (anura).
• Survival differences by race in nasopharyngeal carcinoma.
• The position of the head and centre of mass during the front foot off-drive in skilled and less-skilled cricket batsmen.
• Transgenic overexpression of plasminogen activator inhibitor-1 promotes the development of polycystic ovarian changes in female mice.